Doctors Hospital of Sarasota (FL) Acquires Mazor Robotics’ Renaissance System

Doctors Hospital of Sarasota (FL) Acquires Mazor Robotics’ Renaissance System

U.S. Contacts: EVC Group

Mazor Robotics Ltd. (TASE:MZOR; NASDAQCM:MZOR), the developer of Renaissance™, an innovative surgical guidance system and its complementary products, announced today that Doctors Hospital of Sarasota (FL) has purchased its first Renaissance system.

Doctors Hospital of Sarasota is a general medical and surgical hospital and its spine care team is comprised of some of the area’s most dedicated and respected physicians and clinical staff, who specialize in orthopaedics, neurosurgery and spinal surgery. Doctors Hospital of Sarasota’s physicians are joined by a team of experienced nursing professionals, rehabilitative therapists, pain experts, dietitians and related health care professionals to provide a comprehensive, multidisciplinary approach to your treatment.

Mazor Robotics (TASE: MZOR; NASDAQCM: MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 35,000 implants in the United States, Europe, and Asia. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, the content of which is not part of this press release, please visit .

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.